These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 22664115)

  • 1. Targeted inhibition of VEGF-modulated survival and arsenic sensitivity in acute myeloid leukemia (AML).
    Ding Y; Zhu X; Li Y; Fei J; Zhang Y
    Hematology; 2012 May; 17(3):157-62. PubMed ID: 22664115
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibitory Effects of Arsenic Trioxide and Thalidomide on Angiogenesis and Vascular Endothelial Growth Factor Expression in Leukemia Cells.
    Mohammadi Kian M; Mohammadi S; Tavallaei M; Chahardouli B; Rostami S; Zahedpanah M; Ghavamzadeh A; Nikbakht M
    Asian Pac J Cancer Prev; 2018 Apr; 19(4):1127-1134. PubMed ID: 29699374
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Vascular endothelial growth factor antisense oligodeoxynucleotide enhance drug-sensitivity of myeloid leukemia cells to homoharringtonine].
    Fei J; Zhang H
    Zhonghua Xue Ye Xue Za Zhi; 2005 Jan; 26(1):27-30. PubMed ID: 15946505
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The mechanism of synergistic effects of arsenic trioxide and rapamycin in acute myeloid leukemia cell lines lacking typical t(15;17) translocation.
    Dembitz V; Lalic H; Ostojic A; Vrhovac R; Banfic H; Visnjic D
    Int J Hematol; 2015 Jul; 102(1):12-24. PubMed ID: 25758096
    [TBL] [Abstract][Full Text] [Related]  

  • 5. VEGFA Expression Is Inhibited by Arsenic Trioxide in HUVECs through the Upregulation of Ets-2 and miRNA-126.
    Ge HY; Han ZJ; Tian P; Sun WJ; Xue DX; Bi Y; Yang ZH; Liu P
    PLoS One; 2015; 10(8):e0135795. PubMed ID: 26274316
    [TBL] [Abstract][Full Text] [Related]  

  • 6. miRNA-21 regulates arsenic-induced anti-leukemia activity in myelogenous cell lines.
    Gu J; Zhu X; Li Y; Dong D; Yao J; Lin C; Huang K; Hu H; Fei J
    Med Oncol; 2011 Mar; 28(1):211-8. PubMed ID: 20143188
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Synergistic lethal effect of combined treatment of arsenic trioxide and aclacinomycin on human acute myeloid leukemia cell line KG-1a].
    Ye YB; Xu XJ; Chen YH; Zhang MW; Qiu DF; Guo ZW; He HQ
    Zhonghua Zhong Liu Za Zhi; 2017 Apr; 39(4):256-262. PubMed ID: 28550664
    [No Abstract]   [Full Text] [Related]  

  • 8. Arsenic disulfide-triggered apoptosis and erythroid differentiation in myelodysplastic syndrome and acute myeloid leukemia cell lines.
    Hu XM; Yuan B; Tanaka S; Song MM; Onda K; Tohyama K; Zhou AX; Toyoda H; Hirano T
    Hematology; 2014 Sep; 19(6):352-60. PubMed ID: 24192507
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Silencing of myeloid cell leukemia-1 by small interfering RNA improves chemosensitivity to etoposide in u-937 leukemic cells.
    Jafarlou M; Baradaran B; Shanehbandi D; Saedi TA; Jafarlou V; Karimi P; Othman F
    J Biol Regul Homeost Agents; 2016; 30(1):55-65. PubMed ID: 27049076
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synergistic antiproliferative effect of arsenic trioxide combined with bortezomib in HL60 cell line and primary blasts from patients affected by myeloproliferative disorders.
    Canestraro M; Galimberti S; Savli H; Palumbo GA; Tibullo D; Nagy B; Guerrini F; Piaggi S; Cine N; Metelli MR; Petrini M
    Cancer Genet Cytogenet; 2010 Jun; 199(2):110-20. PubMed ID: 20471514
    [TBL] [Abstract][Full Text] [Related]  

  • 11. EZH2 mediates ATO-induced apoptosis in acute myeloid leukemia cell lines through the Wnt signaling pathway.
    Zhang H; Gu H; Li L; Ren Y; Zhang L
    Tumour Biol; 2016 May; 37(5):5919-23. PubMed ID: 26592252
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Low-dose 1,25-dihydroxyvitamin D(3) combined with arsenic trioxide synergistically inhibits proliferation of acute myeloid leukemia cells by promoting apoptosis.
    Bae JY; Kim JW; Kim I
    Oncol Rep; 2013 Jul; 30(1):485-91. PubMed ID: 23660868
    [TBL] [Abstract][Full Text] [Related]  

  • 13. E3 ubiquitin ligase Cbl-b potentiates the apoptotic action of arsenic trioxide by inhibiting the PI3K/Akt pathway.
    Yingchun L; Xiujuan Q; Jinglei Q; Ye Z; Jing L; Yuee T; Xuejun H; Kezuo H; Yunpeng L
    Braz J Med Biol Res; 2011 Feb; 44(2):105-11. PubMed ID: 21180886
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Arsenic trioxide exerts a double effect on osteoblast growth in vitro.
    Xu WX; Liu Y; Liu SZ; Zhang Y; Qiao GF; Yan J
    Environ Toxicol Pharmacol; 2014 Sep; 38(2):412-9. PubMed ID: 25128771
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Thioredoxin-1 inhibitor PX-12 induces human acute myeloid leukemia cell apoptosis and enhances the sensitivity of cells to arsenic trioxide.
    Tan Y; Bi L; Zhang P; Wang F; Lin F; Ni W; Wu J; Jiang L
    Int J Clin Exp Pathol; 2014; 7(8):4765-73. PubMed ID: 25197347
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Low-dose arsenic trioxide combined with aclacinomycin A synergistically enhances the cytotoxic effect on human acute myelogenous leukemia cell lines by induction of apoptosis.
    Ye Y; Xu X; Zhang M; Qiu D; Bai X; Wang J; Weng G; Zhou R; Guo Z; He H; Yi W; He X; Guo K
    Leuk Lymphoma; 2015; 56(11):3159-67. PubMed ID: 25739941
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Curcumin stimulates reactive oxygen species production and potentiates apoptosis induction by the antitumor drugs arsenic trioxide and lonidamine in human myeloid leukemia cell lines.
    Sánchez Y; Simón GP; Calviño E; de Blas E; Aller P
    J Pharmacol Exp Ther; 2010 Oct; 335(1):114-23. PubMed ID: 20605902
    [TBL] [Abstract][Full Text] [Related]  

  • 18. S100A8-targeting siRNA enhances arsenic trioxide-induced myeloid leukemia cell death by down-regulating autophagy.
    Yang L; Yang M; Zhang H; Wang Z; Yu Y; Xie M; Zhao M; Liu L; Cao L
    Int J Mol Med; 2012 Jan; 29(1):65-72. PubMed ID: 21971985
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A novel combination therapy with arsenic trioxide and parthenolide against pancreatic cancer cells.
    Wang W; Adachi M; Zhang R; Zhou J; Zhu D
    Pancreas; 2009 May; 38(4):e114-23. PubMed ID: 19342982
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Granulocyte colony-stimulating factor potentiates differentiation induction by all-trans retinoic acid and arsenic trioxide and enhances arsenic uptake in the acute promyelocytic leukemia cell line HT93A.
    Iriyama N; Yuan B; Hatta Y; Horikoshi A; Yoshino Y; Toyoda H; Aizawa S; Takeuchi J
    Oncol Rep; 2012 Nov; 28(5):1875-82. PubMed ID: 22940758
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.